TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9473582
log Bayes Factor = <0.0001
Chromosome 6   position 49,488,908  (GRCh37) Explore rs9473582 on Ensembl!
Variant rs9473582 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
L85.9 Epidermal thickening, unspecified
0.021 0.979 0.000
L85.8 Other specified epidermal thickening
0.019 0.981 0.000
L85 Other epidermal thickening
0.018 0.982 0.000
D37.5 Rectum
0.016 0.984 0.000
S22.40 Multiple fractures of ribs (closed)
0.015 0.985 0.000
T43.2 Other and unspecified antidepressants
0.000 0.985 0.015
E16.2 Hypoglycaemia, unspecified
0.014 0.986 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.986 0.014
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.987 0.013
L85.3 Xerosis cutis
0.013 0.987 0.000
L85.2 Keratosis punctata (palmaris et plantaris)
0.013 0.987 0.000
L85.0 Acquired ichthyosis
0.013 0.987 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.987 0.013
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.987 0.013
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris
0.013 0.987 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.987 0.013
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.987 0.013
T39.1 4-Aminophenol derivatives
0.000 0.988 0.012
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.988 0.012
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.989 0.011
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.989 0.011
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.989 0.011
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.990 0.010
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.990 0.010
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.990 0.010
T39.0 Salicylates
0.000 0.990 0.010
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.990 0.010
T43.9 Psychotropic drug, unspecified
0.000 0.990 0.010
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.990 0.010
E16 Other disorders of pancreatic internal secretion
0.010 0.990 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.990 0.010
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.990 0.010
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.990 0.010
T40.2 Other opioids
0.000 0.990 0.010
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.990 0.010
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.990 0.009
T46.7 Peripheral vasodilators
0.000 0.990 0.009
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.990 0.009
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.990 0.010
T40.6 Other and unspecified narcotics
0.000 0.990 0.009
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.991 0.009
T39.4 Antirheumatics, not elsewhere classified
0.000 0.991 0.009
T39.2 Pyrazolone derivatives
0.000 0.991 0.009
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.991 0.009
T43.6 Psychostimulants with abuse potential
0.000 0.991 0.009
T47.0 Histamine H(2)-receptor antagonists
0.000 0.991 0.009
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.991 0.009
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.009 0.991 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.991 0.009
T46.1 Calcium-channel blockers
0.000 0.991 0.009
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.991 0.009
T42.0 Hydantoin derivatives
0.000 0.991 0.009
E16.1 Other hypoglycaemia
0.009 0.991 0.000
T50.8 Diagnostic agents
0.000 0.991 0.009
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.991 0.008
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.991 0.008
T47.7 Emetics
0.000 0.991 0.008
T47.5 Digestants
0.000 0.991 0.008
T47.4 Other laxatives
0.000 0.991 0.008
T47.3 Saline and osmotic laxatives
0.000 0.991 0.008
T47.2 Stimulant laxatives
0.000 0.991 0.008
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.991 0.008
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.991 0.008
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.992 0.008
T40.5 Cocaine
0.000 0.992 0.008
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.992 0.008
T50.4 Drugs affecting uric acid metabolism
0.000 0.992 0.008
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.992 0.008
T50.7 Analeptics and opioid receptor antagonists
0.000 0.992 0.008
T50.5 Appetite depressants
0.000 0.992 0.008
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.992 0.008
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.992 0.008
T50.1 Loop [high-ceiling] diuretics
0.000 0.992 0.008
T50.0 Mineralocorticoids and their antagonists
0.000 0.992 0.008
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.992 0.008
T40.8 Lysergide [LSD]
0.000 0.992 0.008
T40.7 Cannabis (derivatives)
0.000 0.992 0.008
T40.3 Methadone
0.000 0.992 0.008
T40.1 Heroin
0.000 0.992 0.008
T40.0 Opium
0.000 0.992 0.008
D37.9 Digestive organ, unspecified
0.008 0.992 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.992 0.008
T36 Poisoning by systemic antibiotics
0.000 0.992 0.008
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.992 0.008
T47.6 Antidiarrhoeal drugs
0.000 0.992 0.008
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.992 0.008
S52.00 Fracture of upper end of ulna (closed)
0.000 0.992 0.008
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.992 0.008
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.992 0.008
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.992 0.008
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.992 0.008
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.992 0.008
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.992 0.008
T44.0 Anticholinesterase agents
0.000 0.992 0.008
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.992 0.007
T37.5 Antiviral drugs
0.000 0.992 0.007
T37.4 Anthelminthics
0.000 0.992 0.007
T37.3 Other antiprotozoal drugs
0.000 0.992 0.007
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.992 0.007
T37.1 Antimycobacterial drugs
0.000 0.992 0.007
T37.0 Sulphonamides
0.000 0.992 0.007
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.992 0.008
T42.1 Iminostilbenes
0.000 0.993 0.007
T49.9 Topical agent, unspecified
0.000 0.993 0.007
T49.8 Other topical agents
0.000 0.993 0.007
T49.7 Dental drugs, topically applied
0.000 0.993 0.007
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.993 0.007
T49.5 Ophthalmological drugs and preparations
0.000 0.993 0.007
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.993 0.007
T49.3 Emollients, demulcents and protectants
0.000 0.993 0.007
T49.2 Local astringents and local detergents
0.000 0.993 0.007
T49.1 Antipruritics
0.000 0.993 0.007
D37.4 Colon
0.007 0.993 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.007 0.993 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.007 0.993 0.000
E16.4 Abnormal secretion of gastrin
0.007 0.993 0.000
E16.3 Increased secretion of glucagon
0.007 0.993 0.000
S22.4 Multiple fractures of ribs
0.007 0.993 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.007 0.993 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.993 0.007
T41.5 Therapeutic gases
0.000 0.993 0.007
T41.4 Anaesthetic, unspecified
0.000 0.993 0.007
T41.3 Local anaesthetics
0.000 0.993 0.007
T41.2 Other and unspecified general anaesthetics
0.000 0.993 0.007
T41.1 Intravenous anaesthetics
0.000 0.993 0.007
T41.0 Inhaled anaesthetics
0.000 0.993 0.007
D37.0 Lip, oral cavity and pharynx
0.007 0.993 0.000
D37.1 Stomach
0.007 0.993 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.993 0.007
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.993 0.007
T42.2 Succinimides and oxazolidinediones
0.000 0.993 0.007
S82.50 Fracture of medial malleolus (closed)
0.007 0.993 0.000
D37.3 Appendix
0.007 0.993 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.993 0.007
T40.4 Other synthetic narcotics
0.000 0.993 0.007
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.993 0.007
D37.6 Liver, gallbladder and bile ducts
0.006 0.994 0.000
T42.4 Benzodiazepines
0.000 0.994 0.006
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.994 0.006
T48.4 Expectorants
0.000 0.994 0.006
T48.3 Antitussives
0.000 0.994 0.006
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.994 0.006
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.994 0.006
T48.0 Oxytocic drugs
0.000 0.994 0.006
T42.3 Barbiturates
0.000 0.994 0.006
T45.2 Vitamins, not elsewhere classified
0.000 0.994 0.006
D37.2 Small intestine
0.006 0.994 0.000
T45.5 Anticoagulants
0.000 0.994 0.006
T36.9 Systemic antibiotic, unspecified
0.000 0.994 0.006
T36.7 Antifungal antibiotics, systemically used
0.000 0.994 0.006
T36.6 Rifamycins
0.000 0.994 0.006
T36.5 Aminoglycosides
0.000 0.994 0.006
T36.2 Chloramphenicol group
0.000 0.994 0.006
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.994 0.006
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.994 0.006
T45.8 Other primarily systemic and haematological agents
0.000 0.994 0.006
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.994 0.006
T45.6 Fibrinolysis-affecting drugs
0.000 0.994 0.006
T45.4 Iron and its compounds
0.000 0.994 0.006
T45.3 Enzymes, not elsewhere classified
0.000 0.994 0.006
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.994 0.006
T36.4 Tetracyclines
0.000 0.994 0.006
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.994 0.006
T36.3 Macrolides
0.000 0.994 0.005
T48.5 Anti-common-cold drugs
0.000 0.994 0.005
T36.8 Other systemic antibiotics
0.000 0.994 0.005
T38.1 Thyroid hormones and substitutes
0.000 0.994 0.005
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.006 0.994 0.000
S22.41 Multiple fractures of ribs (open)
0.005 0.994 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.994 0.005
T38.9 Other and unspecified hormone antagonists
0.000 0.995 0.005
T38.7 Androgens and anabolic congeners
0.000 0.995 0.005
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.995 0.005
T38.5 Other oestrogens and progestogens
0.000 0.995 0.005
T38.4 Oral contraceptives
0.000 0.995 0.005
T38.2 Antithyroid drugs
0.000 0.995 0.005
T38.0 Glucocorticoids and synthetic analogues
0.000 0.995 0.005
T45.0 Antiallergic and antiemetic drugs
0.000 0.995 0.005
S01.8 Open wound of other parts of head
0.005 0.995 0.000
T36.0 Penicillins
0.000 0.995 0.005
J98.4 Other disorders of lung
0.005 0.995 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.995 0.005
Y40.9 Systemic antibiotic, unspecified
0.005 0.995 0.000
S72.40 Fracture of lower end of femur (closed)
0.000 0.995 0.005
R30.9 Painful micturition, unspecified
0.005 0.995 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.995 0.005
M81.98 Osteoporosis, unspecified (Other)
0.000 0.995 0.005
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.005 0.995 0.000
Q51 Congenital malformations of uterus and cervix
0.005 0.995 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.005 0.995 0.000
Q51.2 Other doubling of uterus
0.004 0.995 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.996 0.004
R41.3 Other amnesia
0.000 0.996 0.004
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.004 0.996 0.000
Y40 Systemic antibiotics
0.004 0.996 0.000
Q51.3 Bicornate uterus
0.004 0.996 0.000
Y42.2 Antithyroid drugs
0.004 0.996 0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.004 0.996 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.996 0.003
Q51.1 Doubling of uterus with doubling of cervix and vagina
0.004 0.996 0.000
D37.7 Other digestive organs
0.004 0.996 0.000
Q51.8 Other congenital malformations of uterus and cervix
0.004 0.996 0.000
Q53.1 Undescended testicle, unilateral
0.004 0.996 0.000
G95.9 Disease of spinal cord, unspecified
0.004 0.996 0.000
Y40.6 Rifamycins
0.004 0.996 0.000
Y40.4 Tetracyclines
0.004 0.996 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.004 0.996 0.000
Q53 Undescended testicle
0.004 0.996 0.000
Q50-Q56 Congenital malformations of genital organs
0.004 0.996 0.000
C92.0 Acute myeloid leukaemia
0.004 0.996 0.000
U88 Agent resistant to multiple antibiotics
0.004 0.996 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.004 0.996 0.000
Y42.1 Thyroid hormones and substitutes
0.004 0.996 0.000
Q12.0 Congenital cataract
0.004 0.996 0.000
S72.10 Pertrochanteric fracture (closed)
0.000 0.996 0.004
Q51.9 Congenital malformation of uterus and cervix, unspecified
0.003 0.996 0.000
Q51.7 Congenital fistulae between uterus and digestive and urinary tracts
0.003 0.996 0.000
Q51.6 Embryonic cyst of cervix
0.003 0.996 0.000
Q51.5 Agenesis and aplasia of cervix
0.003 0.996 0.000
Q51.4 Unicornate uterus
0.003 0.996 0.000
Q51.0 Agenesis and aplasia of uterus
0.003 0.996 0.000
Y42.9 Other and unspecified hormone antagonists
0.003 0.996 0.000
Y42.4 Oral contraceptives
0.003 0.996 0.000
D32.0 Cerebral meninges
0.000 0.997 0.003
S52.0 Fracture of upper end of ulna
0.000 0.997 0.003
E15 Nondiabetic hypoglycaemic coma
0.003 0.997 0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.003 0.997 0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s
0.003 0.997 0.000
U89.8 Agent resistant to other single specified antibiotic
0.003 0.997 0.000
S72.4 Fracture of lower end of femur
0.000 0.997 0.003
Y43.4 Immunosuppressive agents
0.003 0.997 0.000
M06.9 Rheumatoid arthritis, unspecified
0.003 0.997 0.000
Y40.7 Antifungal antibiotics, systemically used
0.003 0.997 0.000
Y40.2 Chloramphenicol group
0.003 0.997 0.000
Y42.7 Androgens and anabolic congeners
0.003 0.997 0.000
Y40.3 Macrolides
0.003 0.997 0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.000 0.997 0.003
Q61.3 Polycystic kidney, unspecified
0.003 0.997 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.000 0.997 0.003
Q64.3 Other atresia and stenosis of urethra and bladder neck
0.003 0.997 0.000
Y40.0 Penicillins
0.003 0.997 0.000
Q53.2 Undescended testicle, bilateral
0.003 0.997 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.997 0.003
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.003 0.997 0.000
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness
0.000 0.997 0.003
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.003 0.997 0.000
Y43 Primarily systemic agents
0.003 0.997 0.000
Q52 Other congenital malformations of female genitalia
0.003 0.997 0.000
Q53.9 Undescended testicle, unspecified
0.003 0.997 0.000
Q53.0 Ectopic testis
0.003 0.997 0.000
U89 Agent resistant to other and unspecified antibiotics
0.003 0.997 0.000
T80.2 Infections following infusion, transfusion and therapeutic injection
0.000 0.997 0.003
Q56 Indeterminate sex and pseudohermaphroditism
0.003 0.997 0.000
Q54 Hypospadias
0.003 0.997 0.000
R41 Other symptoms and signs involving cognitive functions and awareness
0.000 0.997 0.003
Y40.8 Other systemic antibiotics
0.003 0.997 0.000
Y40.5 Aminoglycosides
0.003 0.997 0.000
Y43.0 Antiallergic and antiemetic drugs
0.003 0.997 0.000
Q12 Congenital lens malformations
0.003 0.997 0.000
S72.1 Pertrochanteric fracture
0.000 0.997 0.003
Q64 Other congenital malformations of urinary system
0.003 0.997 0.000
Q85.0 Neurofibromatosis (nonmalignant)
0.000 0.997 0.003
Q55 Other congenital malformations of male genital organs
0.003 0.997 0.000
R41.1 Anterograde amnesia
0.000 0.997 0.003
Y43.1 Antineoplastic antimetabolites
0.003 0.997 0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs
0.003 0.997 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.001 0.997 0.002
Q54.1 Hypospadias, penile
0.003 0.997 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.003 0.997 0.000
Y57.9 Drug or medicament, unspecified
0.003 0.997 0.000
Q38-Q45 Other congenital malformations of the digestive system
0.003 0.997 0.000
C92.1 Chronic myeloid leukaemia
0.003 0.997 0.000
J98.2 Interstitial emphysema
0.003 0.997 0.000
S82.5 Fracture of medial malleolus
0.003 0.997 0.000
O67.9 Intrapartum haemorrhage, unspecified
0.003 0.997 0.000
R41.2 Retrograde amnesia
0.000 0.997 0.003
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.003 0.997 0.000
C92 Myeloid leukaemia
0.003 0.997 0.000
Y57 Other and unspecified drugs and medicaments
0.003 0.997 0.000
Q60-Q64 Congenital malformations of the urinary system
0.003 0.997 0.000
M06.98 Rheumatoid arthritis, unspecified (Other)
0.003 0.997 0.000
Q39 Congenital malformations of oesophagus
0.003 0.997 0.000
I05.1 Rheumatic mitral insufficiency
0.003 0.997 0.000
Y49.5 Other antipsychotics and neuroleptics
0.003 0.997 0.000
Y57.5 X-ray contrast media
0.003 0.997 0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.003 0.997 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.002 0.997 0.000
Q52.1 Doubling of vagina
0.002 0.997 0.000
Q54.8 Other hypospadias
0.002 0.997 0.000
J98 Other respiratory disorders
0.003 0.997 0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver
0.003 0.997 0.000
S52.01 Fracture of upper end of ulna (open)
0.000 0.997 0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.002 0.997 0.000
H18.8 Other specified disorders of cornea
0.000 0.997 0.003
M06.0 Seronegative rheumatoid arthritis
0.003 0.997 0.000
Q55.0 Absence and aplasia of testis
0.002 0.997 0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments
0.002 0.997 0.000
M15.99 Polyosteoarthritis, unspecified
0.002 0.997 0.000
C92.7 Other myeloid leukaemia
0.002 0.998 0.000
C92.2 Subacute myeloid leukaemia
0.002 0.998 0.000
J98.5 Diseases of mediastinum, not elsewhere classified
0.002 0.998 0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.002 0.998 0.000
Q39.6 Diverticulum of oesophagus
0.002 0.998 0.000
Y43.9 Primarily systemic agent, unspecified
0.002 0.998 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.002 0.998 0.000
Y43.6 Enzymes, not elsewhere classified
0.002 0.998 0.000
Y43.5 Acidifying and alkalising agents
0.002 0.998 0.000
Y43.2 Antineoplastic natural products
0.002 0.998 0.000
Y44.5 Thrombolytic drugs
0.002 0.998 0.000
Q61 Cystic kidney disease
0.002 0.998 0.000
Q52.9 Congenital malformation of female genitalia, unspecified
0.002 0.998 0.000
Q52.8 Other specified congenital malformations of female genitalia
0.002 0.998 0.000
Q52.7 Other congenital malformations of vulva
0.002 0.998 0.000
Q52.6 Congenital malformation of clitoris
0.002 0.998 0.000
Q52.4 Other congenital malformations of vagina
0.002 0.998 0.000
Q52.3 Imperforate hymen
0.002 0.998 0.000
Q52.2 Congenital rectovaginal fistula
0.002 0.998 0.000
Q52.0 Congenital absence of vagina
0.002 0.998 0.000
Y42.5 Other oestrogens and progestogens
0.002 0.998 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.002 0.998 0.000
Q64.7 Other congenital malformations of bladder and urethra
0.002 0.998 0.000
Q64.4 Malformation of urachus
0.002 0.998 0.000
S72.41 Fracture of lower end of femur (open)
0.000 0.998 0.002
Q56.4 Indeterminate sex, unspecified
0.002 0.998 0.000
Q56.3 Pseudohermaphroditism, unspecified
0.002 0.998 0.000
Q56.2 Female pseudohermaphroditism, not elsewhere classified
0.002 0.998 0.000
Q56.1 Male pseudohermaphroditism, not elsewhere classified
0.002 0.998 0.000
Q56.0 Hermaphroditism, not elsewhere classified
0.002 0.998 0.000
Q12.9 Congenital lens malformation, unspecified
0.002 0.998 0.000
Q12.8 Other congenital lens malformations
0.002 0.998 0.000
Q12.4 Spherophakia
0.002 0.998 0.000
Q12.3 Congenital aphakia
0.002 0.998 0.000
Q12.2 Coloboma of lens
0.002 0.998 0.000
Q12.1 Congenital displaced lens
0.002 0.998 0.000
Q44.7 Other congenital malformations of liver
0.002 0.998 0.000
Q54.4 Congenital chordee
0.002 0.998 0.000
Q54.3 Hypospadias, perineal
0.002 0.998 0.000
Q54.2 Hypospadias, penoscrotal
0.002 0.998 0.000
Q45 Other congenital malformations of digestive system
0.002 0.998 0.000
S72 Fracture of femur
0.000 0.998 0.002
Y53 Agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
S72.11 Pertrochanteric fracture (open)
0.000 0.998 0.002
Q64.9 Congenital malformation of urinary system, unspecified
0.002 0.998 0.000
Q64.8 Other specified congenital malformations of urinary system
0.002 0.998 0.000
Q64.6 Congenital diverticulum of bladder
0.002 0.998 0.000
Q64.5 Congenital absence of bladder and urethra
0.002 0.998 0.000
Q64.2 Congenital posterior urethral valves
0.002 0.998 0.000
Q64.1 Exstrophy of urinary bladder
0.002 0.998 0.000
Q64.0 Epispadias
0.002 0.998 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.002 0.998 0.000
S72.90 Fracture of femur, part unspecified (closed)
0.000 0.998 0.002
Q52.5 Fusion of labia
0.002 0.998 0.000
Q54.0 Hypospadias, balanic
0.002 0.998 0.000
S72.9 Fracture of femur, part unspecified
0.000 0.998 0.002
M53.3 Sacrococcygeal disorders, not elsewhere classified
0.002 0.998 0.000
O00.1 Tubal pregnancy
0.002 0.998 0.000
Q55.9 Congenital malformation of male genital organ, unspecified
0.002 0.998 0.000
Q55.8 Other specified congenital malformations of male genital organs
0.002 0.998 0.000
Q55.5 Congenital absence and aplasia of penis
0.002 0.998 0.000
Q55.4 Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate
0.002 0.998 0.000
Q55.3 Atresia of vas deferens
0.002 0.998 0.000
Q55.1 Hypoplasia of testis and scrotum
0.002 0.998 0.000
Q85.8 Other phakomatoses, not elsewhere classified
0.000 0.998 0.002
M06 Other rheumatoid arthritis
0.002 0.998 0.000
Q85 Phakomatoses, not elsewhere classified
0.000 0.998 0.002
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.002 0.998 0.000
J39.0 Retropharyngeal and parapharyngeal abscess
0.002 0.998 0.000
M15.9 Polyarthrosis, unspecified
0.002 0.998 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.002 0.998 0.000
M06.04 Seronegative rheumatoid arthritis (Hand)
0.002 0.998 0.000
M15.2 Bouchard's nodes (with arthropathy)
0.002 0.998 0.000
Q39.4 Oesophageal web
0.002 0.998 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.001 0.998 0.001
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.001 0.998 0.001
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.001 0.998 0.001
Y51.1 Other parasympathomimetics [cholinergics]
0.001 0.998 0.001
Y51.0 Anticholinesterase agents
0.001 0.998 0.001
R17 Unspecified jaundice
0.002 0.998 0.000
U84 Resistance to other antimicrobial drugs
0.002 0.998 0.000
U83 Resistance to other antibiotics
0.002 0.998 0.000
U82 Resistance to betalactam antibiotics
0.002 0.998 0.000
U85 Resistance to antineoplastic drugs
0.002 0.998 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.002 0.998 0.000
Q43.0 Meckel's diverticulum
0.002 0.998 0.000
U89.9 Agent resistant to unspecified antibiotic
0.002 0.998 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.001 0.998 0.002
Q38 Other congenital malformations of tongue, mouth and pharynx
0.002 0.998 0.000
Y55.4 Expectorants
0.002 0.998 0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.002 0.998 0.000
Q45.8 Other specified congenital malformations of digestive system
0.002 0.998 0.000
Q42 Congenital absence, atresia and stenosis of large intestine
0.002 0.998 0.000
Q41 Congenital absence, atresia and stenosis of small intestine
0.002 0.998 0.000
H10.9 Conjunctivitis, unspecified
0.002 0.998 0.000
O75.7 Vaginal delivery following previous Caesarean section
0.002 0.998 0.000
Q44.5 Other congenital malformations of bile ducts
0.002 0.998 0.000
Y58 Bacterial vaccines
0.002 0.998 0.000
Y44 Agents primarily affecting blood constituents
0.002 0.998 0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified
0.002 0.998 0.000
T86.0 Bone-marrow transplant rejection
0.002 0.998 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.001 0.998 0.001
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.001 0.998 0.001
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.001 0.998 0.001
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.002 0.998 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.002 0.998 0.000
C92.5 Acute myelomonocytic leukaemia
0.002 0.998 0.000
C92.3 Myeloid sarcoma
0.002 0.998 0.000
M15 Polyarthrosis
0.002 0.998 0.000
Q15 Other congenital malformations of eye
0.002 0.998 0.000
Q40 Other congenital malformations of upper alimentary tract
0.002 0.998 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.002 0.998 0.000
Y57.7 Vitamins, not elsewhere classified
0.002 0.998 0.000
Y57.4 Pharmaceutical excipients
0.002 0.998 0.000
Y57.3 Alcohol deterrents
0.002 0.998 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.002 0.998 0.000
Y57.1 Lipotropic drugs
0.002 0.998 0.000
Y57.0 Appetite depressants [anorectics]
0.002 0.998 0.000
Q39.9 Congenital malformation of oesophagus, unspecified
0.002 0.998 0.000
Q39.8 Other congenital malformations of oesophagus
0.002 0.998 0.000
Q39.5 Congenital dilatation of oesophagus
0.002 0.998 0.000
Q39.3 Congenital stenosis and stricture of oesophagus
0.002 0.998 0.000
Q39.2 Congenital tracheooesophageal fistula without atresia
0.002 0.998 0.000
Q39.1 Atresia of oesophagus with tracheooesophageal fistula
0.002 0.998 0.000
Q39.0 Atresia of oesophagus without fistula
0.002 0.998 0.000
Q55.2 Other congenital malformations of testis and scrotum
0.002 0.998 0.000
Q43 Other congenital malformations of intestine
0.002 0.998 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.002 0.998 0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)
0.002 0.998 0.000
Q61.2 Polycystic kidney, adult type
0.002 0.998 0.000
Q10 Congenital malformations of eyelid, lachrymal apparatus and orbit
0.002 0.998 0.000
J98.8 Other specified respiratory disorders
0.002 0.998 0.000
J98.6 Disorders of diaphragm
0.002 0.998 0.000
Q55.6 Other congenital malformations of penis
0.002 0.998 0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter
0.002 0.998 0.000
M15.1 Heberden's nodes (with arthropathy)
0.002 0.998 0.000
J98.3 Compensatory emphysema
0.002 0.998 0.000
Q44.4 Choledochal cyst
0.002 0.998 0.000
Q44.3 Congenital stenosis and stricture of bile ducts
0.002 0.998 0.000
Q44.2 Atresia of bile ducts
0.002 0.998 0.000
Q44.1 Other congenital malformations of gallbladder
0.002 0.998 0.000
Q44.0 Agenesis, aplasia and hypoplasia of gallbladder
0.002 0.998 0.000
Q61.5 Medullary cystic kidney
0.002 0.998 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.002 0.998 0.000
Y55.5 Anticommon cold drugs
0.002 0.998 0.000
Y55.3 Antitussives
0.002 0.998 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.002 0.998 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.002 0.998 0.000
Y55.0 Oxytocic drugs
0.002 0.998 0.000
M06.08 Seronegative rheumatoid arthritis (Other)
0.002 0.998 0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.002 0.998 0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.002 0.998 0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.002 0.998 0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.002 0.998 0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament
0.002 0.998 0.000
Q50.3 Other congenital malformations of ovary
0.002 0.998 0.000
Q50.2 Congenital torsion of ovary
0.002 0.998 0.000
Q50.1 Developmental ovarian cyst
0.002 0.998 0.000
Q50.0 Congenital absence of ovary
0.002 0.998 0.000
M15.3 Secondary multiple arthrosis
0.002 0.998 0.000
Z57.5 Occupational exposure to toxic agents in other industries
0.002 0.998 0.000
Q35-Q37 Cleft lip and cleft palate
0.002 0.998 0.000
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns
0.002 0.998 0.000
S82.51 Fracture of medial malleolus (open)
0.002 0.998 0.000
Q61.8 Other cystic kidney diseases
0.002 0.998 0.000
Q61.1 Polycystic kidney, infantile type
0.002 0.998 0.000
Q16 Congenital malformations of ear causing impairment of hearing
0.002 0.998 0.000
Q13 Congenital malformations of anterior segment of eye
0.002 0.998 0.000
Q11 Anophthalmos, microphthalmos and macrophthalmos
0.002 0.998 0.000
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)
0.000 0.998 0.002
Q38.5 Congenital malformations of palate, not elsewhere classified
0.002 0.998 0.000
Q14 Congenital malformations of posterior segment of eye
0.002 0.998 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.002 0.998 0.000
Q30-Q34 Congenital malformations of the respiratory system
0.002 0.998 0.000
C92.4 Acute promyelocytic leukaemia
0.002 0.998 0.000
M15.8 Other polyarthrosis
0.002 0.998 0.000
Q15.0 Congenital glaucoma
0.002 0.998 0.000
Y54.4 Loop [high-ceiling] diuretics
0.002 0.998 0.000
Y59 Other and unspecified vaccines and biological substances
0.002 0.998 0.000
Q43.9 Congenital malformation of intestine, unspecified
0.002 0.998 0.000
Q44.6 Cystic disease of liver
0.002 0.998 0.000
Q45.9 Congenital malformation of digestive system, unspecified
0.002 0.998 0.000
Q45.2 Congenital pancreatic cyst
0.002 0.998 0.000
Q45.1 Annular pancreas
0.002 0.998 0.000
Q45.0 Agenesis, aplasia and hypoplasia of pancreas
0.002 0.998 0.000
Y49.9 Psychotropic drug, unspecified
0.002 0.998 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
Y49.7 Psychostimulants with abuse potential
0.002 0.998 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.002 0.998 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.998 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.998 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.998 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.002 0.998 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
Y53.7 Emetics
0.002 0.998 0.000
Y53.6 Antidiarrhoeal drugs
0.002 0.998 0.000
Y53.5 Digestants
0.002 0.998 0.000
Y53.3 Saline and osmotic laxatives
0.002 0.998 0.000
Y53.2 Stimulant laxatives
0.002 0.998 0.000
Y53.0 Histamine H2-receptor antagonists
0.002 0.998 0.000
Y57.8 Other drugs and medicaments
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.